Author: Ha, Seok Gyun; Oh, Kyung Jin; Ko, Kwang-Pil; Sun, Yong Han; Ryoo, Eell; Tchah, Hann; Jeon, In Sang; Kim, Hyo Jeong; Ahn, Jung Min; Cho, Hye-Kyung
Title: Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children Document date: 2018_9_18
ID: yrbo0hdk_5
Snippet: Among these patients, macrolide-unresponsive MP pneumonia cases were clinically defined as persistent fever ≥ 38.0°C at ≥ 72 hours after macrolide treatment in this study. The macrolide-unresponsive MP pneumonia cases were divided into four groups, PMC, CST, DXC, and LFX. The PMC group was defined as cases treated with PMC without a change of antibiotics. The CST, DXC, and LFX groups were defined as cases with treatment added on (CST) or cha.....
Document: Among these patients, macrolide-unresponsive MP pneumonia cases were clinically defined as persistent fever ≥ 38.0°C at ≥ 72 hours after macrolide treatment in this study. The macrolide-unresponsive MP pneumonia cases were divided into four groups, PMC, CST, DXC, and LFX. The PMC group was defined as cases treated with PMC without a change of antibiotics. The CST, DXC, and LFX groups were defined as cases with treatment added on (CST) or changed to secondary treatment (DXC, LFX) because of persistent symptoms despite macrolide treatment.
Search related documents:
Co phrase search for related documents- cst add and secondary treatment: 1
- lfx DXC CST PMC group and macrolide treatment: 1, 2
- lfx DXC CST PMC group and PMC group: 1, 2
- lfx DXC CST PMC group and secondary treatment: 1, 2
Co phrase search for related documents, hyperlinks ordered by date